13F HOLDINGS REPORT
Soleus Capital Management, L.P.
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001802630-23-000010
Total Value
$1.08B
Positions
91
Other Managers
0
Confidential Omitted
No
Holdings (91)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 1,250,000 | $91.3M | 8.42% |
| 2 | UNITED THERAPEUTICS CORP DEL | UTHR | 287,165 | $64.9M | 5.98% |
| 3 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 6,052,164 | $61.7M | 5.70% |
| 4 | EDAP TMS S A | EDAP | 6,256,784 | $43.9M | 4.05% |
| 5 | SURMODICS INC | 868873100 | 1,230,862 | $39.5M | 3.64% |
| 6 | ORGANOGENESIS HLDGS INC | ORGO | 12,296,163 | $39.1M | 3.61% |
| 7 | GSK PLC | GLAXF | 943,000 | $34.2M | 3.15% |
| 8 | HUMANA INC | HUM | 68,802 | $33.5M | 3.09% |
| 9 | IRADIMED CORP | IRMD | 628,206 | $27.9M | 2.57% |
| 10 | VAXCYTE INC | PCVX | 499,650 | $25.5M | 2.35% |
| 11 | TREACE MED CONCEPTS INC | 89455T109 | 1,907,823 | $25.0M | 2.31% |
| 12 | TG THERAPEUTICS INC | TGTX | 2,884,382 | $24.1M | 2.22% |
| 13 | NEUROPACE INC | NPCE | 2,466,205 | $24.0M | 2.21% |
| 14 | ARCELLX INC | ACLX | 643,777 | $23.1M | 2.13% |
| 15 | TANGO THERAPEUTICS INC | TNGX | 1,929,019 | $21.7M | 2.00% |
| 16 | INSULET CORP | PODD | 127,680 | $20.4M | 1.88% |
| 17 | EVOLUS INC | EOLS | 2,078,000 | $19.0M | 1.75% |
| 18 | AXOGEN INC | AXGN | 3,785,829 | $18.9M | 1.75% |
| 19 | CHARLES RIV LABS INTL INC | 159864107 | 96,064 | $18.8M | 1.74% |
| 20 | CELCUITY INC | CELC | 2,056,484 | $18.8M | 1.73% |
| 21 | THE BEAUTY HEALTH COMPANY | 88331L108 | 2,806,720 | $16.9M | 1.56% |
| 22 | AXSOME THERAPEUTICS INC | AXSM | 237,500 | $16.6M | 1.53% |
| 23 | SMITH & NEPHEW PLC | SNNUF | 653,900 | $16.2M | 1.49% |
| 24 | RIGEL PHARMACEUTICALS INC | RIGL | 14,803,015 | $16.0M | 1.48% |
| 25 | IMMUNOVANT INC | IMVT | 399,599 | $15.3M | 1.42% |
| 26 | KRYSTAL BIOTECH INC | KRYS | 117,892 | $13.7M | 1.26% |
| 27 | SI-BONE INC | SIBN | 642,289 | $13.6M | 1.26% |
| 28 | CVS HEALTH CORP | CVS | 192,554 | $13.4M | 1.24% |
| 29 | ATRICURE INC | ATRC | 306,000 | $13.4M | 1.24% |
| 30 | ESSA PHARMA INC | 29668H708 | 4,287,094 | $13.2M | 1.22% |
| 31 | MEREO BIOPHARMA GROUP PLC | MREO | 9,677,419 | $12.5M | 1.15% |
| 32 | BAUSCH HEALTH COS INC | 071734107 | 1,408,801 | $11.6M | 1.07% |
| 33 | VERASTEM INC | VSTM | 1,347,369 | $11.0M | 1.01% |
| 34 | BIONTECH SE | BNTX | 98,000 | $10.6M | 0.98% |
| 35 | INHIBRX INC | INBX | 549,183 | $10.1M | 0.93% |
| 36 | RAYZEBIO INC | 75525N107 | 451,163 | $10.0M | 0.92% |
| 37 | SOLENO THERAPEUTICS INC | SLNO | 325,000 | $9.6M | 0.88% |
| 38 | MERUS N V | N5749R100 | 384,490 | $9.1M | 0.84% |
| 39 | BICYCLE THERAPEUTICS PLC | BCYC | 391,800 | $7.9M | 0.73% |
| 40 | BIOATLA INC | BCAB | 4,356,197 | $7.4M | 0.68% |
| 41 | PHARVARIS N V | PHVS | 343,975 | $7.2M | 0.66% |
| 42 | COMPASS PATHWAYS PLC | CMPS | 964,550 | $7.1M | 0.66% |
| 43 | NUVALENT INC | NUVL | 154,416 | $7.1M | 0.65% |
| 44 | INSPIRE MED SYS INC | 457730109 | 35,600 | $7.1M | 0.65% |
| 45 | EXACT SCIENCES CORP | 30063P105 | 102,196 | $7.0M | 0.64% |
| 46 | NURIX THERAPEUTICS INC | NRIX | 814,000 | $6.4M | 0.59% |
| 47 | BIOLIFE SOLUTIONS INC | BLFS | 439,000 | $6.1M | 0.56% |
| 48 | JASPER THERAPEUTICS INC | JSPRW | 8,300,980 | $5.8M | 0.54% |
| 49 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 1,239,777 | $5.6M | 0.52% |
| 50 | NOVOCURE LTD | NVCR | 344,100 | $5.6M | 0.51% |
| 51 | INSMED INC | INSM | 218,000 | $5.5M | 0.51% |
| 52 | 89BIO INC | 282559103 | 346,033 | $5.3M | 0.49% |
| 53 | UROGEN PHARMA LTD | URGN | 372,000 | $5.2M | 0.48% |
| 54 | ACADIA PHARMACEUTICALS INC | ACAD | 244,627 | $5.1M | 0.47% |
| 55 | THERATECHNOLOGIES INC | 88338H704 | 2,331,376 | $5.0M | 0.46% |
| 56 | C4 THERAPEUTICS INC | CCCC | 2,692,020 | $5.0M | 0.46% |
| 57 | CASTLE BIOSCIENCES INC | CSTL | 283,500 | $4.8M | 0.44% |
| 58 | INSPIREMD INC | NSPR | 1,378,128 | $4.5M | 0.42% |
| 59 | TARSUS PHARMACEUTICALS INC | TARS | 250,000 | $4.4M | 0.41% |
| 60 | SERES THERAPEUTICS INC | MCRB | 1,820,983 | $4.3M | 0.40% |
| 61 | MIRUM PHARMACEUTICALS INC | MIRM | 103,000 | $3.3M | 0.30% |
| 62 | APPLIED THERAPEUTICS INC | 03828A101 | 1,192,626 | $3.0M | 0.27% |
| 63 | BIOHAVEN LTD | BHVN | 113,800 | $3.0M | 0.27% |
| 64 | GENEDX HOLDINGS CORP | WGSWW | 781,396 | $2.8M | 0.26% |
| 65 | KINIKSA PHARMACEUTICALS LTD | KNSA | 157,349 | $2.7M | 0.25% |
| 66 | NATERA INC | NTRA | 61,377 | $2.7M | 0.25% |
| 67 | DESIGN THERAPEUTICS INC | DSGN | 1,025,000 | $2.4M | 0.22% |
| 68 | LYRA THERAPEUTICS INC | LYRA | 592,417 | $2.3M | 0.21% |
| 69 | PRAXIS PRECISION MEDICINES I | PRAX | 1,150,000 | $2.0M | 0.18% |
| 70 | XENON PHARMACEUTICALS INC | XENE | 52,000 | $1.8M | 0.16% |
| 71 | SYNDAX PHARMACEUTICALS INC | SNDX | 119,500 | $1.7M | 0.16% |
| 72 | AADI BIOSCIENCE INC | WHWK | 333,227 | $1.6M | 0.15% |
| 73 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 123,748 | $1.6M | 0.15% |
| 74 | ALKERMES PLC | ALKS | 54,400 | $1.5M | 0.14% |
| 75 | VIKING THERAPEUTICS INC | VKTX | 122,200 | $1.4M | 0.12% |
| 76 | ANNEXON INC | ANNX | 515,400 | $1.2M | 0.11% |
| 77 | LIQUIDIA CORPORATION | LQDA | 175,000 | $1.1M | 0.10% |
| 78 | AVITA MEDICAL INC | AVHHL | 75,000 | $1.1M | 0.10% |
| 79 | KARUNA THERAPEUTICS INC | 48576A100 | 6,440 | $1.1M | 0.10% |
| 80 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 104,000 | $1.1M | 0.10% |
| 81 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 88,073 | $1.0M | 0.09% |
| 82 | Y-MABS THERAPEUTICS INC | 984241109 | 157,182 | $856,642 | 0.08% |
| 83 | APOGEE THERAPEUTICS INC | APGE | 35,000 | $745,500 | 0.07% |
| 84 | ALNYLAM PHARMACEUTICALS INC | ALNY | 3,900 | $690,690 | 0.06% |
| 85 | GALECTO INC | 36322Q107 | 897,657 | $645,864 | 0.06% |
| 86 | DELCATH SYS INC | DCTH | 144,958 | $587,080 | 0.05% |
| 87 | ARS PHARMACEUTICALS INC | SPRY | 150,000 | $567,000 | 0.05% |
| 88 | XERIS BIOPHARMA HOLDINGS INC | XERS | 304,083 | $565,594 | 0.05% |
| 89 | XILIO THERAPEUTICS INC | XLO | 226,941 | $478,846 | 0.04% |
| 90 | IMMUNIC INC | IMUX | 300,000 | $441,000 | 0.04% |
| 91 | KEROS THERAPEUTICS INC | KROS | 12,700 | $404,876 | 0.04% |